Annovis Bio Inc.
Quick facts
Phase 3 pipeline
- buntanetap/posiphen · Neurology; Alzheimer's disease
Buntanetap/posiphen inhibits translation of amyloid precursor protein (APP) and tau, reducing production of amyloid-beta and tau pathology in the brain.
Phase 1 pipeline
- Posiphen · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: